The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Moroney, John
One or more keywords matched the following properties of Moroney, John
PropertyValue
overview John Moroney, MD, specializes in the diagnosis and treatment of gynecologic cancers, with a focus on providing skilled and personalized longitudinal care. He believes that access to innovative surgical techniques and targeted medical therapies are essential in achieving optimal outcomes. Dr. Moroney is the principal investigator (PI) at the University of Chicago for NRG Oncology, a National Cancer Institute-supported clinical trials cooperative group. He also serves as the PI for numerous other industry-sponsored clinical trials.
One or more keywords matched the following items that are connected to Moroney, John
Item TypeName
Concept Neoplasm Staging
Concept Uterine Hemorrhage
Concept Gynecologic Surgical Procedures
Concept Stem Cell Transplantation
Concept Drug Delivery Systems
Concept Sirolimus
Concept TOR Serine-Threonine Kinases
Concept Vaginal Smears
Concept Survival Rate
Concept Cervix Uteri
Concept Drug Administration Schedule
Concept Fellowships and Scholarships
Concept Retrospective Studies
Concept Cystadenocarcinoma, Serous
Concept Disease-Free Survival
Academic Article Responses to liposomal Doxorubicin, bevacizumab, and temsirolimus in metaplastic carcinoma of the breast: biologic rationale and implications for stem-cell research in breast cancer.
Academic Article Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors.
Academic Article Current recommendations and recent progress in endometrial cancer.
Academic Article Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma.
Academic Article PIK3CA mutations in patients with advanced cancers treated with PI3K/AKT/mTOR axis inhibitors.
Academic Article What is the benefit of bevacizumab combined with chemotherapy in patients with recurrent ovarian, fallopian tube or primary peritoneal malignancies?
Academic Article Laparoscopy training in gynecologic oncology fellowship programs.
Academic Article Phase I clinical trials in 85 patients with gynecologic cancer: the M. D. Anderson Cancer Center experience.
Academic Article Normal endometrial cells in liquid-based cervical cytology specimens in women aged 40 or older.
Academic Article Phase I study of the antiangiogenic antibody bevacizumab and the mTOR/hypoxia-inducible factor inhibitor temsirolimus combined with liposomal doxorubicin: tolerance and biological activity.
Academic Article A phase I trial of liposomal doxorubicin, bevacizumab, and temsirolimus in patients with advanced gynecologic and breast malignancies.
Academic Article Safety and Clinical Activity of Atezolizumab Plus Bevacizumab in Patients with Ovarian Cancer: A Phase Ib Study.
Academic Article Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial.
Academic Article Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors.
Academic Article A randomized phase II trial of everolimus and letrozole or hormonal therapy in women with advanced, persistent or recurrent endometrial carcinoma: A GOG Foundation study.
Concept Sentinel Lymph Node
Concept Drug-Related Side Effects and Adverse Reactions
Concept Cytoreduction Surgical Procedures
Concept Response Evaluation Criteria in Solid Tumors
Academic Article A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283.
Academic Article Common gynecologic problems in geriatric-aged women.
Academic Article Mirvetuximab Soravtansine in FRa-Positive, Platinum-Resistant Ovarian Cancer.
Academic Article Robotic surgical staging for cervical cancer diagnosed during pregnancy: Immediate versus delayed definitive treatment.
Academic Article NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.
Search Criteria
  • National Cancer Institute
  • U
  • S